Stockreport

Relmada Therapeutics Inc (RLMD) Q4 2025 Earnings Call Highlights: Strategic Advancements and ... [Yahoo! Finance]

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com
PDF Net Proceeds from Stock Offering: Approximately $94 million from an offering announced on November 5, 2025. Private Financing: $160 million with net proceeds of appro [Read more]